Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AstraZeneca Says CEO McKillop Will Stay Through 2006 Despite Rumors

This article was originally published in The Pink Sheet Daily

Executive Summary

The British financial press speculates that McKillop could depart to become chairman of the Royal Bank of Scotland, but the bank says its current chairman could stay on for an additional five years. AstraZeneca board and McKillop have reached a new contract that would extend his employment beyond 2005, company says.

You may also be interested in...



AstraZeneca CEO Designate Brennan Will Take Reins From McKillop In 2006

Selection of U.S. head David Brennan to succeed retiring CEO Tom McKillop was the result of a search that focused on internal candidates.

AstraZeneca CEO Designate Brennan Will Take Reins From McKillop In 2006

Selection of U.S. head David Brennan to succeed retiring CEO Tom McKillop was the result of a search that focused on internal candidates.

AstraZeneca Refocuses On Risk Management, Elevates Development Oversight

Former Exec VP-Product Strategy & Licensing John Patterson will assume the board-level position of exec director-development effective Jan. 1. Regulatory affairs overhaul will include a review of ongoing Phase III programs for Galida, Cerovive and Symbicort.

Topics

UsernamePublicRestriction

Register

ID1132115

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel